Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Primary progressive multiple sclerosis

Recruiting

Investigational

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational

France

Participants:18–64 years

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drugNo placebo

Study on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dimethyl Fumarate

Contact Research Centre

Ischaemic stroke

Recruiting

Registered drugNo placebo

Study on Colchicine and Ticagrelor for Preventing Ischemic Stroke in Patients with Atherosclerosis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Colchicine

Contact Research Centre

Pathogen resistance

Recruiting

Registered drugNo placebo

Study on Piperacillin-Tazobactam and Temocillin for Treating Severe Infections in ICU Patients with ESBL-Producing Gram-Negative Bacteria

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Meropenem Anhydrous

Contact Research Centre

Relapsing multiple sclerosis+2

Recruiting

Registered drug

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Teriflunomide

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drugNo placebo

Study on the Effects of Annual vs. Semi-Annual Ocrelizumab Infusions in Patients with Active Multiple Sclerosis After 2 Years of Initial Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ocrelizumab

Contact Research Centre

Ischaemic stroke

Not yet recruiting

Registered drugNo placebo

Effectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Tenecteplase

Contact Research Centre

Pneumonia+1

Not yet recruiting

Registered drug

Early Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Ischaemic stroke

Not yet recruiting

Registered drugNo placebo

Comparing tenecteplase and mechanical clot removal versus mechanical clot removal alone for adults with a large ischemic stroke

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Tenecteplase

Contact Research Centre

Multiple sclerosis

Not recruiting

Investigational

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Investigational

France

Participants:18–64 years
Substances:Frexalimab

Contact Research Centre

Primary progressive multiple sclerosis

Not recruiting

Investigational

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Investigational

France

Participants:18–64 years
Substances:Tolebrutinib

Contact Research Centre

Find therapies in clinical trials near you

16 trials match your criteria

Primary progressive multiple sclerosis

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Secondary progressive multiple sclerosis

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Multiple sclerosis

Study on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis

Ischaemic stroke

Study on Colchicine and Ticagrelor for Preventing Ischemic Stroke in Patients with Atherosclerosis

Pathogen resistance

Study on Piperacillin-Tazobactam and Temocillin for Treating Severe Infections in ICU Patients with ESBL-Producing Gram-Negative Bacteria

Relapsing multiple sclerosis+2

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Multiple sclerosis

Study on the Effects of Annual vs. Semi-Annual Ocrelizumab Infusions in Patients with Active Multiple Sclerosis After 2 Years of Initial Treatment

Ischaemic stroke

Effectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy

Pneumonia+1

Early Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)

Ischaemic stroke

Comparing tenecteplase and mechanical clot removal versus mechanical clot removal alone for adults with a large ischemic stroke

Multiple sclerosis

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Primary progressive multiple sclerosis

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.